CONTEXT: Commercial announcement of another in what is becoming the biggest rend this year – access to RWD. I don’t know about you, but I’m intrigued by the phrase “research Continue Reading
CONTEXT: When the world falls apart, we still (thankfully) have studies focusing on the stuff (viruses) that impact us when we aren’t focusing on COVID | This is a retrospective Continue Reading
CONTEXT: At first glance this interview article about an app developed to measure a set of performance indicators may seem to be on the fringes of “proper science”. However, patients Continue Reading
CONTEXT: Commercial announcement of a significant acquisition in the RWD space | Is this the biggest deal we will see this year or is there more to come? IMPACT: Medium Continue Reading
CONTEXT: Prospective observational study in releasing remitting multiple sclerosis (RRMS) with a relatively old treatment showing a fairly content and stable patient population in Germany | Study conducted between 2015 Continue Reading
CONTEXT: This retrospective analysis of an at-home monitoring system gives hope for suffers of age-related macular degeneration (AMD) | The large sale analysis of US patients showed the system could Continue Reading
CONTEXT: Relatively small scale RWE study (102 patients) on the variation in biomarker testing in NSCLC patients in the Netherlands. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 Continue Reading
CONTEXT: Publication of an RWE study in type 2 diabetes patients treated with SGLT2 and GLP1- receptor antagonists showing a long term reduction in risk of coronary heart disease | Continue Reading
CONTEXT: Publication from the analysis of the first 500 patients enrolled in a pulmonary arterial hypertension (PAH) registry showed promising treatment results in stabilising or reducing their 1-year mortality risk Continue Reading
CONTEXT: Market report on the still buoyant RWE market, or at least the valuations of the market are buoyant | Different day, different figure IMPACT: Low READ TIME: 1 min Continue Reading
